Press release: World Drug Safety Conference hears call for wider use of cognitive safety testing in drug development

April 30, 2015 In a call to the pharmaceutical industry at the World Drug Safety Conference in Chicago last week (April 22 to 23), a leading developer of cognitive assessment software, Cambridge Cognition plc (Cambridge, UK; LSE AIM: COG), stressed the increasing regulatory and clinical need to expand cognitive safety testing beyond CNS-targeted drugs. Speaking to an international audience of …